ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,728,096, issued on Sept. 8, was assigned to Synthon B.V. (Nijmegen, Netherlands).
"Pharmaceutical composition comprising enzalutamide" was invented by Sara Fradera Gelabert (Sant Boi de Llobregat, Spain), Lisardo Alvarez Fernandez (Sant Boi de Llobregat, Spain) and Rohit Kumar (Sant Boi de Llobregat, Spain).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a tablet composition comprising a granulate consisting of a co-precipitate on a substrate, wherein the co-precipitate comprises enzalutamide in amorphous form and a cellulosic concentration enhancing polymer. The invention further relates to the use of said composition as ...